Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

International Consortium for Health Outcomes Measurement (ICHOM): Standardized Patient-Centered Outcomes Measurement Set for Heart Failure Patients.

Burns DJP, Arora J, Okunade O, Beltrame JF, Bernardez-Pereira S, Crespo-Leiro MG, Filippatos GS, Hardman S, Hoes AW, Hutchison S, Jessup M, Kinsella T, Knapton M, Lam CSP, Masoudi FA, McIntyre H, Mindham R, Morgan L, Otterspoor L, Parker V, Persson HE, Pinnock C, Reid CM, Riley J, Stevenson LW, McDonagh TA.

JACC Heart Fail. 2020 Mar;8(3):212-222. doi: 10.1016/j.jchf.2019.09.007. Epub 2019 Dec 11. Review.

2.

ST2 in patients with severe aortic stenosis and heart failure.

Cai A, Miyazawa A, Sunderland N, Piper SE, Gibbs TGJ, Wang D, Redding S, Amin-Youseff G, Wendler O, Byrne J, MacCarthy PA, Shah AM, McDonagh TA, Dworakowski R.

Cardiol J. 2019 Jun 21. doi: 10.5603/CJ.a2019.0052. [Epub ahead of print]

3.

Does rhythm matter in acute heart failure? An insight from the British Society for Heart Failure National Audit.

Anderson SG, Shoaib A, Myint PK, Cleland JG, Hardman SM, McDonagh TA, Dargie H, Keavney B, Garratt CJ, Mamas MA.

Clin Res Cardiol. 2019 Nov;108(11):1276-1286. doi: 10.1007/s00392-019-01463-5. Epub 2019 Apr 8.

4.

The impact of catheter ablation for atrial fibrillation in heart failure.

Moschonas K, Nabeebaccus A, Okonko DO, McDonagh TA, Murgatroyd FD, Dhillon P, Scott PA.

J Arrhythm. 2018 Sep 3;35(1):33-42. doi: 10.1002/joa3.12115. eCollection 2019 Feb. Review.

5.

Mortality after admission for heart failure in the UK compared with Japan.

Nagai T, Sundaram V, Rothnie K, Quint JK, Shoaib A, Shiraishi Y, Kohsaka S, Piper S, McDonagh TA, Hardman SMC, Goda A, Mizuno A, Kohno T, Rigby AS, Yoshikawa T, Clark AL, Anzai T, Cleland JGF.

Open Heart. 2018 Sep 11;5(2):e000811. doi: 10.1136/openhrt-2018-000811. eCollection 2018.

6.

Is heart failure with mid range ejection fraction (HFmrEF) a distinct clinical entity or an overlap group?

Webb J, Draper J, Fovargue L, Sieniewicz B, Gould J, Claridge S, Barton C, Smith S, Tondel K, Rajani R, Kapetanakis S, Rinaldi CA, McDonagh TA, Razavi R, Carr-White G.

Int J Cardiol Heart Vasc. 2018 Sep 6;21:1-6. doi: 10.1016/j.ijcha.2018.06.001. eCollection 2018 Dec.

7.

Validation of U.S. mortality prediction models for hospitalized heart failure in the United Kingdom and Japan.

Nagai T, Sundaram V, Shoaib A, Shiraishi Y, Kohsaka S, Rothnie KJ, Piper S, McDonagh TA, Hardman SMC, Goda A, Mizuno A, Sawano M, Rigby AS, Quint JK, Yoshikawa T, Clark AL, Anzai T, Cleland JGF.

Eur J Heart Fail. 2018 Aug;20(8):1179-1190. doi: 10.1002/ejhf.1210. Epub 2018 May 30.

8.

A cost effectiveness study establishing the impact and accuracy of implementing the NICE guidelines lowering plasma NTproBNP threshold in patients with clinically suspected heart failure at our institution.

Webb J, Draper J, Rua T, Yiu Y, Piper S, Teall T, Fovargue L, Bolca E, Jackson T, Claridge S, Sieniewicz B, Porter B, McDiarmid A, Rajani R, Kapetanakis S, Rinaldi CA, Razavi R, McDonagh TA, Carr-White G.

Int J Cardiol. 2018 Apr 15;257:131-136. doi: 10.1016/j.ijcard.2017.10.126.

PMID:
29506684
9.

In-hospital worsening heart failure: a clinically relevant endpoint?

Clark AL, Cherif M, McDonagh TA, Squire IB.

ESC Heart Fail. 2018 Feb;5(1):9-18. doi: 10.1002/ehf2.12195. Epub 2017 Jul 18. Review.

10.

Corrigendum to '2017 ESC/EACTS Guidelines for the management of valvular heart disease' [Eur J Cardiothorac Surg 2017;52:616-664].

Falk V, Baumgartner H, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL, Roffi M, Alfieri O, Agewall S, Ahlsson A, Barbato E, Bueno H, Collet JP, Coman IM, Czerny M, Delgado V, Fitzsimons D, Folliguet T, Gaemperli O, Habib G, Harringer W, Haude M, Hindricks G, Katus HA, Knuuti J, Kolh P, Leclercq C, McDonagh TA, Piepoli MF, Pierard LA, Ponikowski P, Rosano GMC, Ruschitzka F, Shlyakhto E, Simpson IA, Sousa-Uva M, Stepinska J, Tarantini G, Tchétché D, Aboyans V.

Eur J Cardiothorac Surg. 2017 Oct 1;52(4):832. doi: 10.1093/ejcts/ezx363. No abstract available.

11.

Biological Phenotypes of Heart Failure With Preserved Ejection Fraction.

Lewis GA, Schelbert EB, Williams SG, Cunnington C, Ahmed F, McDonagh TA, Miller CA.

J Am Coll Cardiol. 2017 Oct 24;70(17):2186-2200. doi: 10.1016/j.jacc.2017.09.006. Review.

12.

Hearts and Minds: Real-Life Cardiotoxicity With Clozapine in Psychosis.

Joy G, Whiskey E, Bolstridge M, Porras-Segovia A, McDonagh TA, Plymen CM, Shergill SS.

J Clin Psychopharmacol. 2017 Dec;37(6):708-712. doi: 10.1097/JCP.0000000000000792.

PMID:
29049078
13.

Biomarkers in Persistent AF and Heart Failure: Impact of Catheter Ablation Compared with Rate Control.

Jones DG, Haldar SK, Donovan J, McDonagh TA, Sharma R, Hussain W, Markides V, Wong T.

Pacing Clin Electrophysiol. 2016 Sep;39(9):926-34. doi: 10.1111/pace.12919. Epub 2016 Aug 17.

14.

Ironing out iron deficiency in heart failure.

McDonagh TA.

Eur J Heart Fail. 2016 Jul;18(7):796-7. doi: 10.1002/ejhf.597. Epub 2016 Jul 13. No abstract available.

15.

Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489].

Anker SD, Schroeder S, Atar D, Bax JJ, Ceconi C, Cowie MR, Crisp A, Dominjon F, Ford I, Ghofrani HA, Gropper S, Hindricks G, Hlatky MA, Holcomb R, Honarpour N, Jukema JW, Kim AM, Kunz M, Lefkowitz M, Floch CL, Landmesser U, McDonagh TA, McMurray JJ, Merkely B, Packer M, Prasad K, Revkin J, Rosano GM, Somaratne R, Stough WG, Voors AA, Ruschitzka F.

Eur J Heart Fail. 2016 Jun;18(6):727. doi: 10.1002/ejhf.591. No abstract available.

16.

Heart Failure Association of the European Society of Cardiology heart failure nurse curriculum.

Riley JP, Astin F, Crespo-Leiro MG, Deaton CM, Kienhorst J, Lambrinou E, McDonagh TA, Rushton CA, Stromberg A, Filippatos G, Anker SD.

Eur J Heart Fail. 2016 Jul;18(7):736-43. doi: 10.1002/ejhf.568. Epub 2016 May 25.

17.

Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency.

Anker SD, Schroeder S, Atar D, Bax JJ, Ceconi C, Cowie MR, Crisp A, Dominjon F, Ford I, Ghofrani HA, Gropper S, Hindricks G, Hlatky MA, Holcomb R, Honarpour N, Jukema JW, Kim AM, Kunz M, Lefkowitz M, Le Floch C, Landmesser U, McDonagh TA, McMurray JJ, Merkely B, Packer M, Prasad K, Revkin J, Rosano GM, Somaratne R, Stough WG, Voors AA, Ruschitzka F.

Eur J Heart Fail. 2016 May;18(5):482-9. doi: 10.1002/ejhf.516. Epub 2016 Apr 12. Review. Erratum in: Eur J Heart Fail. 2016 Jun;18(6):727.

18.

Heart failure specialization in Europe.

Westenbrink BD, Brugts JJ, McDonagh TA, Filippatos G, Ruschitzka F, van Laake LW.

Eur J Heart Fail. 2016 Apr;18(4):347-9. doi: 10.1002/ejhf.506. Epub 2016 Apr 12. No abstract available.

19.

Serial galectin-3 for the monitoring of optimally treated stable chronic heart failure: A pilot study.

Piper SE, de Courcey J, Sherwood RA, Amin-Youssef GF, McDonagh TA.

Int J Cardiol. 2016 Mar 15;207:279-81. doi: 10.1016/j.ijcard.2016.01.179. Epub 2016 Jan 13. No abstract available.

PMID:
26808993
20.

Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology.

Budts W, Roos-Hesselink J, Rädle-Hurst T, Eicken A, McDonagh TA, Lambrinou E, Crespo-Leiro MG, Walker F, Frogoudaki AA.

Eur Heart J. 2016 May 7;37(18):1419-27. doi: 10.1093/eurheartj/ehv741. Epub 2016 Jan 18. Review. No abstract available.

21.

Chemotherapy-related Cardiomyopathy.

Piper SE, McDonagh TA.

Eur Cardiol. 2015 Jul;10(1):19-24. doi: 10.15420/ecr.2015.10.01.19. Review.

22.

Serial soluble ST2 for the monitoring of pharmacologically optimised chronic stable heart failure.

Piper SE, Sherwood RA, Amin-Youssef GF, Shah AM, McDonagh TA.

Int J Cardiol. 2015 Jan 15;178:284-91. doi: 10.1016/j.ijcard.2014.11.097. Epub 2014 Nov 12.

PMID:
25465308
23.

Do plasma concentrations of apelin predict prognosis in patients with advanced heart failure?

Dalzell JR, Jackson CE, Chong KS, McDonagh TA, Gardner RS.

Biomark Med. 2014;8(6):807-13. doi: 10.2217/bmm.14.33.

PMID:
25224937
24.

Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency.

Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, McDonagh TA, Parkhomenko A, Tavazzi L, Levesque V, Mori C, Roubert B, Filippatos G, Ruschitzka F, Anker SD.

ESC Heart Fail. 2014 Sep;1(1):52-58. doi: 10.1002/ehf2.12006.

25.

Impact of prolonged implantable cardioverter-defibrillator arrhythmia detection times on outcomes: a meta-analysis.

Scott PA, Silberbauer J, McDonagh TA, Murgatroyd FD.

Heart Rhythm. 2014 May;11(5):828-35. doi: 10.1016/j.hrthm.2014.02.009. Epub 2014 Feb 12. Review.

PMID:
24530622
26.

Heart failure association of the European society of cardiology specialist heart failure curriculum.

McDonagh TA, Gardner RS, Lainscak M, Nielsen OW, Parissis J, Filippatos G, Anker SD.

Eur J Heart Fail. 2014 Feb;16(2):151-62. doi: 10.1002/ejhf.41. Epub 2014 Jan 8.

27.

The effect of respiratory scoring on the diagnosis and classification of sleep disordered breathing in chronic heart failure.

Ward NR, Roldao V, Cowie MR, Rosen SD, McDonagh TA, Simonds AK, Morrell MJ.

Sleep. 2013 Sep 1;36(9):1341-8. doi: 10.5665/sleep.2960.

28.

A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure.

Jones DG, Haldar SK, Hussain W, Sharma R, Francis DP, Rahman-Haley SL, McDonagh TA, Underwood SR, Markides V, Wong T.

J Am Coll Cardiol. 2013 May 7;61(18):1894-903. doi: 10.1016/j.jacc.2013.01.069. Epub 2013 Mar 7.

29.

The Year in Cardiology 2012: heart failure.

McDonagh TA.

Eur Heart J. 2013 Feb;34(7):499-502. doi: 10.1093/eurheartj/ehs470. Epub 2013 Jan 14. No abstract available.

PMID:
23321348
30.

A reduction in total isovolumic time with cardiac resynchronisation therapy is a predictor of clinical outcomes.

Guha K, Mantziari L, Sharma R, McDonagh TA, Gibson D, Duncan AM.

Int J Cardiol. 2013 Sep 20;168(1):382-7. doi: 10.1016/j.ijcard.2012.09.035. Epub 2012 Oct 3.

PMID:
23041011
31.

Socioeconomically but not medically deprived?

Dargie HJ, McDonagh TA.

Circulation. 2012 Aug 28;126(9):1006-8. doi: 10.1161/CIRCULATIONAHA.112.124537. No abstract available.

PMID:
22927470
32.

Utility of overnight pulse oximetry and heart rate variability analysis to screen for sleep-disordered breathing in chronic heart failure.

Ward NR, Cowie MR, Rosen SD, Roldao V, De Villa M, McDonagh TA, Simonds A, Morrell MJ.

Thorax. 2012 Nov;67(11):1000-5. doi: 10.1136/thoraxjnl-2012-201684. Epub 2012 Jul 17.

33.

Newly diagnosed heart failure: change in quality of life, mood, and illness beliefs in the first 6 months after diagnosis.

Mulligan K, Mehta PA, Fteropoulli T, Dubrey SW, McIntyre HF, McDonagh TA, Sutton GC, Walker DM, Cowie MR, Newman S.

Br J Health Psychol. 2012 Sep;17(3):447-62. doi: 10.1111/j.2044-8287.2011.02047.x. Epub 2011 Aug 25.

PMID:
22107031
34.

Treatment of left ventricular non-compaction with cardiac resynchronization therapy.

Guha K, Treibel TA, Roussin I, Prasad SK, Duncan AM, Brookes C, McDonagh TA, Sharma R.

QJM. 2013 Jun;106(6):575-9. doi: 10.1093/qjmed/hcr201. Epub 2011 Oct 22. No abstract available.

PMID:
22021572
35.

Clinical trials in acute heart failure: simpler solutions to complex problems. Consensus document arising from a European Society of Cardiology cardiovascular round-table think tank on acute heart failure, 12 May 2009.

McDonagh TA, Komajda M, Maggioni AP, Zannad F, Gheorghiade M, Metra M, Dargie HJ.

Eur J Heart Fail. 2011 Dec;13(12):1253-60. doi: 10.1093/eurjhf/hfr126. Epub 2011 Sep 29. Review.

36.

Pulmonary hypertension in left heart disease: a review.

Corte TJ, McDonagh TA, Wort SJ.

Int J Cardiol. 2012 May 3;156(3):253-8. doi: 10.1016/j.ijcard.2011.06.013. Epub 2011 Jun 23. Review.

PMID:
21703699
37.

Quantifying the added value of BNP in suspected heart failure in general practice: an individual patient data meta-analysis.

Kelder JC, Cowie MR, McDonagh TA, Hardman SM, Grobbee DE, Cost B, Hoes AW.

Heart. 2011 Jun;97(12):959-63. doi: 10.1136/hrt.2010.220426. Epub 2011 Apr 8.

PMID:
21478382
38.

European Society of Cardiology Heart Failure Association Standards for delivering heart failure care.

McDonagh TA, Blue L, Clark AL, Dahlström U, Ekman I, Lainscak M, McDonald K, Ryder M, Strömberg A, Jaarsma T; European Society of Cardiology Heart Failure Association Committee on Patient Care.

Eur J Heart Fail. 2011 Mar;13(3):235-41. doi: 10.1093/eurjhf/hfq221. Epub 2010 Dec 15.

39.

Myocardial apelin production is reduced in humans with left ventricular systolic dysfunction.

Chandrasekaran B, Kalra PR, Donovan J, Hooper J, Clague JR, McDonagh TA.

J Card Fail. 2010 Jul;16(7):556-61. doi: 10.1016/j.cardfail.2010.02.004. Epub 2010 Apr 3.

PMID:
20610231
40.

Novel biomarkers in heart failure: an overview.

Dalzell JR, Jackson CE, McDonagh TA, Gardner RS.

Biomark Med. 2009 Oct;3(5):453-63. doi: 10.2217/bmm.09.42.

PMID:
20477516
41.

Declining renal function after myocardial infarction predicts poorer long-term outcome.

Aengus Murphy C, Robb SD, Weir RA, McDonagh TA, Dargie HJ.

Eur J Cardiovasc Prev Rehabil. 2010 Apr;17(2):181-6. doi: 10.1097/HJR.0b013e328332d48b.

PMID:
19829117
42.

Challenges in advanced chronic heart failure: drug therapy.

McDonagh TA.

Future Cardiol. 2008 Sep;4(5):517-25. doi: 10.2217/14796678.4.5.517.

PMID:
19804345
43.

Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK.

Mehta PA, Dubrey SW, McIntyre HF, Walker DM, Hardman SM, Sutton GC, McDonagh TA, Cowie MR.

Heart. 2009 Nov;95(22):1851-6. doi: 10.1136/hrt.2008.156034. Epub 2009 Jul 8.

PMID:
19587390
44.

Plasma apelin concentration is depressed following acute myocardial infarction in man.

Weir RA, Chong KS, Dalzell JR, Petrie CJ, Murphy CA, Steedman T, Mark PB, McDonagh TA, Dargie HJ, McMurray JJ.

Eur J Heart Fail. 2009 Jun;11(6):551-8. doi: 10.1093/eurjhf/hfp043. Epub 2009 Apr 6.

45.

Mode of death in patients with newly diagnosed heart failure in the general population.

Mehta PA, Dubrey SW, McIntyre HF, Walker DM, Hardman SM, Sutton GC, McDonagh TA, Cowie MR.

Eur J Heart Fail. 2008 Nov;10(11):1108-16. doi: 10.1016/j.ejheart.2008.09.004. Epub 2008 Oct 5.

46.

Screening for asymptomatic left ventricular dysfunction using B-type natriuretic Peptide.

McDonagh TA, McDonald K, Maisel AS.

Congest Heart Fail. 2008 Jul-Aug;14(4 Suppl 1):5-8. Review.

47.

The reign of the natriuretic peptides in patients with heart failure continues.

Gardner RS, McDonagh TA.

Biomark Med. 2008 Oct;2(5):437-9. doi: 10.2217/17520363.2.5.437. No abstract available.

48.

Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failure.

Gardner RS, Chong KS, O'Meara E, Jardine A, Ford I, McDonagh TA.

Eur Heart J. 2007 Dec;28(24):3027-33. Epub 2007 Oct 29.

PMID:
17967819
49.

Can we use B-type natriuretic peptides to monitor patients with heart failure?

McDonagh TA, Gardner RS, Chong KS, Dargie HJ.

Biomark Med. 2007 Oct;1(3):349-53. doi: 10.2217/17520363.1.3.349.

PMID:
20477379
50.

B-type natriuretic peptides in heart failure.

Gardner RS, Chong KS, McDonagh TA.

Biomark Med. 2007 Aug;1(2):243-50. doi: 10.2217/17520363.1.2.243.

PMID:
20477399

Supplemental Content

Loading ...
Support Center